Alicia Menendez-Pineirua

Cuernavaca, MOR 62000, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Sexual Identity and Condomless Sex Among Mexican MSM: The Overlooked Role of Heterosexual-Identified MSM.

Sexual Identity and Condomless Sex Among Mexican MSM: The Overlooked Role of Heterosexual-Identified MSM.

Journal: Journal of sex research

Published: January 06, 2026

Who is accessing PrEP in Mexico? Profiling users and identifying the unreached among high-risk MSM.

Who is accessing PrEP in Mexico? Profiling users and identifying the unreached among high-risk MSM.

Journal: AIDS (London, England)

Published: May 30, 2025

Experience of a Nationwide implementation of single-tablet second-generation integrase inhibitors-based treatment in Mexico.

Experience of a Nationwide implementation of single-tablet second-generation integrase inhibitors-based treatment in Mexico.

Journal: IJID regions

Published: January 03, 2025

Access to diagnostic testing for invasive fungal diseases and other opportunistic infections in Mexican health care centers caring for patients living with HIV.

Access to diagnostic testing for invasive fungal diseases and other opportunistic infections in Mexican health care centers caring for patients living with HIV.

Journal: BMC health services research

Published: October 27, 2024

Comparative Effectiveness of Switching to Bictegravir From Dolutegravir-, Efavirenz-, or Raltegravir-Based Antiretroviral Therapy Among Individuals With HIV Who are Virologically Suppressed.

Comparative Effectiveness of Switching to Bictegravir From Dolutegravir-, Efavirenz-, or Raltegravir-Based Antiretroviral Therapy Among Individuals With HIV Who are Virologically Suppressed.

Journal: Open forum infectious diseases

Published: June 28, 2024

Comparative effectiveness of bictegravir versus dolutegravir, raltegravir, and efavirenz-based antiretroviral therapy among treatment-naïve individuals with HIV.

Comparative effectiveness of bictegravir versus dolutegravir, raltegravir, and efavirenz-based antiretroviral therapy among treatment-naïve individuals with HIV.

Journal: European journal of internal medicine

Published: May 06, 2024

How the COVID-19 pandemic and the health system's response reduced HIV testing and increased late diagnoses in Mexico.

How the COVID-19 pandemic and the health system's response reduced HIV testing and increased late diagnoses in Mexico.

Journal: AIDS (London, England)

Published: January 09, 2024

Characteristics and outcomes of people living with HIV hospitalised at tertiary healthcare institutions during the COVID-19 pandemic in Mexico City.

Characteristics and outcomes of people living with HIV hospitalised at tertiary healthcare institutions during the COVID-19 pandemic in Mexico City.

Journal: BMC infectious diseases

Published: October 06, 2023

SARS-CoV-2 infection in health care workers during the first 2-years of the pandemic at a cancer hospital in Mexico.

SARS-CoV-2 infection in health care workers during the first 2-years of the pandemic at a cancer hospital in Mexico.

Journal: American journal of infection control

Published: August 19, 2023

Retiring the term AIDS for more descriptive language.

Retiring the term AIDS for more descriptive language.

Journal: The lancet. HIV

Published: August 15, 2023

Risk factors associated with HCV co-infection amongst MSM and transgender women living with HIV in Mexico City: A case-control study.

Risk factors associated with HCV co-infection amongst MSM and transgender women living with HIV in Mexico City: A case-control study.

Journal: Annals of hepatology

Published: April 18, 2022

Clinical Follow-Up in People Living with HIV During the COVID-19 Pandemic in Mexico.

Clinical Follow-Up in People Living with HIV During the COVID-19 Pandemic in Mexico.

Journal: AIDS and behavior

Published: February 09, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026